4//SEC Filing
Leggett Thomas 4
Accession 0000899243-20-025360
CIK 0001701541other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 6:09 PM ET
Size
8.7 KB
Accession
0000899243-20-025360
Insider Transaction Report
Form 4
Leggett Thomas
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2020-09-14$10.86/sh+3,000$32,580→ 3,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-09-14−3,000→ 230,171 totalExercise: $10.86Exp: 2029-09-08→ Common Stock (3,000 underlying) - Sale
Common Stock
2020-09-14$31.00/sh−3,000$93,000→ 0 total
Footnotes (2)
- [F1]Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 5, 2020.
- [F2]25% of the shares subject to this option vested and became exercisable on September 5, 2020, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001774690
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 6:09 PM ET
- Size
- 8.7 KB